Come contattare il centro
Centro HCP
Il background storico del Rigshospitalet risale al primo vero ospedale della Danimarca, il "Royal Frederiks Hospital", fondato per prendersi cura e curare i poveri di Copenhagen con attaccamento. L'ospedale fu inaugurato nel 1757 e si trovava a Bredgade, dove oggi si trova il Kunstindustrimuseet. Nel 1910 l'ospedale divenne parte dello stato e si trasferì nella sede attuale in Blegdamsvej. L'ospedale ha anche cambiato nome in Rigshospitalet, poiché in futuro dovrebbe essere a disposizione di tutti i cittadini del Regno. Il moderno Rigshospital, con i suoi alti edifici grigi, risale agli anni '1960 e oggi fa parte della Regione della Capitale.
Immagine: Ole Morten Nygård
Contatti
Rigshospitalet, Copenhagen, Denmark
Team
Dr Steffen HAMANN
Danmark
Pr Michael LARSEN
Danmark
Line Kessel
Danmark
Test clinici
A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.
This is a single-arm open label interventional safety trial with RP patients, who receive weekly TES for 6 months on 1 eye followed by observation for another 6 months without stimulation. The primary outcome measure is safety, indicated by the frequency and severity of adverse events.
Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene
Safety and Efficacy of Emixustat in Stargardt Disease.
Efficacy and safety of QLT091001 in subjects with Inherited Retinal Disease (IRD) caused by gene mutations.
A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT.
Clinical and Genetic Examination of Usher Syndrome Patients’ Cohort in Europe.
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Long-Term Non-Interventional Latanoprost Study
Advanced Characterization of Autosomal Dominant Optic Atrophy.
Transcorneal Electrical Stimulation - Multicenter Safety Study.
Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen
Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Factors: New Perspectives
A Head-to-head Comparison of Ultrasound Versus Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis
Global Patient Registry of Inherited Retinal Disease